A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment
This study has been completed.
Sponsor:
ALK-Abelló A/S
Information provided by (Responsible Party):
ALK-Abelló A/S
ClinicalTrials.gov Identifier:
NCT00773240
First received: October 15, 2008
Last updated: August 27, 2011
Last verified: August 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2009 |
| Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
No publications provided by ALK-Abelló A/S
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):